Kronox Lab Sciences Completes 64.26% Stake Sale and Overhauls Leadership
Kronox Lab Sciences Ltd · Change in Management · 30 Sept 2026, 12:07 am
Kronox Lab Sciences Completes 64.26% Stake Sale and Overhauls Leadership Kronox Lab Sciences announced that sellers completed the transfer of 2,38,44,000 shares (64.26% stake) to Indo Borax & Chemicals on 29th Sep'26 under their SPA. Sellers retain a 9.95% stake and cease to be promoters. Following the change of control, the board reconstituted entirely: Suresh Kalra was appointed MD & CEO, Sunil Malhotra as Whole-time Director, and Shashikant Bharuka as CFO. Outgoing promoters Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani resigned from executive roles and entered 36-month transition consultancy agreements at ₹2.10 crore each.
Original exchange filing (PDF)
More announcements from Kronox Lab Sciences Ltd
- The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November .... · 11 Nov 2026
- The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 10, 2026 for Indo Borax .... · 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd · 06 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 05, 2026 for Indo Borax & Chemicals Ltd · 06 Nov 2026
- IIFL Capital Services Ltd (formerly known as IIFL Securities Ltd) ("Manager to the Open Offer") has submitted to BSE a copy of Offer Opening Public Announcement in accordance with Regulation .... · 05 Nov 2026
- Results -Financail Resutls for the Quarter and Half Year ended September 30, 2026 · 05 Nov 2026
- Kronox Lab Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 05 Nov 2026
- Outcome of Board Meeting held on Thursday, November 05, 2026 inter to consider and approve unaudited Standalone Financial Results for the Quarter and Half Year ended September 30, 2026 · 05 Nov 2026
